Surgeons in Europe now have access to MyBone, a patient specific 3D printed bone, to treat patients with severe facial deformations.
This 3D printed bone is made of hydroxyapatite, a calcium phosphate which is the main mineral component of natural bone. MyBone is 3D printed with a porous structure by Cerhum, a medical device company in Liège, Belgium.
MyBone is authorised under the Medical Device Regulation 2017/745 (MDR), registered with the Belgium Competent Authority (FAMHP, registration number BE/CA01/1-72228) and ISO 13485 certified.
MyBone is made available to a first batch of maxillofacial and orthopaedic surgeons as a patient-specific implant. For example, two years ago, as part of a controlled release phase, a complex and challenging case was done in which a patient received such a 3D printed bone implant. The patient is doing well, and the implant looks exactly like natural bone on a recent CT scan.
Dr Christophe Ronsmans, head of department of plastic surgery, CHR Liege says: “Given the complexity of the defect, it would have been impossible to achieve such perfection from an aesthetic point of view and such a functional result with current methods.”
Grégory Nolens, Cerhum founder and CSO said: “We are very proud to have successfully gathered vital clinical data and passed all the regulatory hurdles with a synthetic bone graft that is safe and effective. Our 3D printed bone implants offer a unique, patented porous structure that allows ingrowth of blood vessels. This process, called vascularisation is key to achieve successful bone ingrowth. As a result, MyBone has shown 7x faster bone ingrowth than currently available bone graft granules. Due to extremely positive feedback of maxillofacial surgeons so far, Cerhum is expanding its portfolio into the dental and oncological market.”